CNS Pharmaceuticals (CNSP) Short Interest Ratio & Short Volume → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free CNSP Stock Alerts $0.21 0.00 (-0.48%) (As of 02:36 PM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media CNS Pharmaceuticals Short Interest DataCurrent Short Volume31,200 sharesPrevious Short Volume23,100 sharesChange Vs. Previous Month+35.06%Dollar Volume Sold Short$6,552.00Short Interest Ratio / Days to Cover0.1Last Record DateApril 30, 2024Outstanding Shares10,640,000 sharesFloat Size10,140,000 sharesShort Percent of Float0.31%Today's Trading Volume58,295 sharesAverage Trading Volume371,655 sharesToday's Volume Vs. Average16% Short Selling CNS Pharmaceuticals ? Sign up to receive the latest short interest report for CNS Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCNSP Short Interest Over TimeCNSP Days to Cover Over TimeCNSP Percentage of Float Shorted Over Time Ad Banyan Hill PublishingTrump’s Former Wingman Bets Big on AIOne of his AI company’s earliest investors was the CIA’s venture capital arm called In-Q-Tel … named after Q, the fictional character who makes gadgets for James Bond. Soon, an alphabet soup of 30 government agencies would entrust the company with their most sensitive information.Get the full story here. CNS Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202431,200 shares $6,552.00 +35.1%0.3%0.1 $0.21 4/15/202423,100 shares $5,530.14 -53.8%0.2%0.1 $0.24 3/31/202450,000 shares $18,100.00 -51.8%0.5%0.1 $0.36 3/15/2024103,800 shares $36,983.94 +91.5%1.3%0.3 $0.36 2/29/202454,200 shares $15,067.60 -47.2%0.7%0.1 $0.28 2/15/2024102,600 shares $29,035.80 -87.2%1.3%0.3 $0.28 Get the Latest News and Ratings for CNSP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CNS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024802,400 shares $198,995.20 +317.1%10.2%2.6 $0.25 1/15/2024192,400 shares $179,894.00 -10.8%3.1%1.6 $0.94 12/31/2023215,700 shares $273,939.00 +298.0%3.5%2.1 $1.27 12/15/202354,200 shares $93,766.00 +30.6%0.9%0.5 $1.73 11/30/202341,500 shares $86,320.00 +75.1%0.8%0.6 $2.08 11/15/202323,700 shares $45,504.00 -50.3%0.5%0.3 $1.92 10/31/202347,700 shares $98,739.00 -36.6%1.2%0.3 $2.07 10/15/202375,200 shares $101,520.00 +22.7%1.8%0.5 $1.35 9/30/202361,300 shares $69,882.00 -8.5%1.5%0.5 $1.14 9/15/202367,000 shares $100,500.00 -45.2%1.6%0.4 $1.50 8/31/2023122,300 shares $209,133.00 +69.6%3.0%0.6 $1.71 8/15/202372,100 shares $123,291.00 -3.1%1.8%0.2 $1.71 7/31/202374,400 shares $168,144.00 +11.4%1.8%0.2 $2.26 7/15/202366,800 shares $142,952.00 -70.0%1.6%0 $2.14 6/30/2023222,600 shares $496,398.00 +7.2%5.5%0.1 $2.23 6/15/2023207,600 shares $448,416.00 -9.4%5.1%0.1 $2.16 5/31/2023229,100 shares $421,544.00 +91.6%5.7%0.1 $1.84 5/15/2023119,600 shares $166,244.00 -44.6%3.0%0 $1.39 4/30/2023215,800 shares $325,858.00 +306.4%10.0%0.1 $1.51 4/15/202353,100 shares $124,785.00 +410.6%3.1%0 $2.35 3/31/202310,400 shares $10,400.00 -57.6%0.6%0 $1.00 3/15/202324,500 shares $30,380.00 +49.4%2.3%0.6 $1.24 2/28/202316,400 shares $30,340.00 +62.4%1.6%0.4 $1.85 2/15/202310,100 shares $17,372.00 +206.1%1.0%0.3 $1.72 1/31/20233,300 shares $7,293.00 +153.9%0.3%0.1 $2.21 1/15/20231,300 shares $3,120.00 -63.9%0.1%0.1 $2.40 12/30/20223,600 shares $8,640.00 -65.4%0.3%0.2 $2.40 12/15/202210,400 shares $26,520.00 -2.8%0.8%0.6 $2.55 11/30/202210,700 shares $32,421.00 -88.5%1.1%0.7 $3.03 11/15/202293,200 shares $17,717.32 +24.4%N/A0.5 $0.19 10/31/202274,900 shares $11,984.00 +21.2%N/A0.4 $0.16 10/15/202261,800 shares $12,656.64 -65.7%N/A0.3 $0.20 9/30/2022180,000 shares $32,220.00 -14.6%N/A0.7 $0.18 9/15/2022210,800 shares $51,856.80 +15.0%N/A0.4 $0.25The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. CNSP Short Interest - Frequently Asked Questions What is CNS Pharmaceuticals' current short interest? Short interest is the volume of CNS Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 31,200 shares of CNSP short. 0.31% of CNS Pharmaceuticals' shares are currently sold short. Learn More on CNS Pharmaceuticals' current short interest. What is a good short interest percentage for CNS Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.31% of CNS Pharmaceuticals' floating shares are currently sold short. Is CNS Pharmaceuticals' short interest increasing or decreasing? CNS Pharmaceuticals saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 31,200 shares, an increase of 35.1% from the previous total of 23,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is CNS Pharmaceuticals' float size? CNS Pharmaceuticals currently has issued a total of 10,640,000 shares. Some of CNS Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CNS Pharmaceuticals currently has a public float of 10,140,000 shares. How does CNS Pharmaceuticals' short interest compare to its competitors? 0.31% of CNS Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to CNS Pharmaceuticals: CohBar, Inc. (0.59%), 60 Degrees Pharmaceuticals, Inc. (1.31%), Sonoma Pharmaceuticals, Inc. (0.30%), Salarius Pharmaceuticals, Inc. (1.65%), Notable Labs, Ltd. (0.08%), Dermata Therapeutics, Inc. (1.28%), Avenue Therapeutics, Inc. (3.26%), Altamira Therapeutics Ltd. (6.57%), Virpax Pharmaceuticals, Inc. (0.91%), Galmed Pharmaceuticals Ltd. (1.49%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short CNS Pharmaceuticals stock? Short selling CNSP is an investing strategy that aims to generate trading profit from CNS Pharmaceuticals as its price is falling. CNSP shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CNS Pharmaceuticals? A short squeeze for CNS Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CNSP, which in turn drives the price of the stock up even further. How often is CNS Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNSP, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: CohBar Short Interest Data 60 Degrees Pharmaceuticals Short Interest Data Sonoma Pharmaceuticals Short Interest Data Salarius Pharmaceuticals Short Interest Data Notable Labs Short Interest Data Dermata Therapeutics Short Interest Data Avenue Therapeutics Short Interest Data Altamira Therapeutics Short Interest Data Virpax Pharmaceuticals Short Interest Data Galmed Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CNSP) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyDoes this make you sick?Allegiance Goldis this a buy and hold stock?Tips4TradersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market Alerts